DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Heinemann V, Rivera F, O’Neil BH. et al.
A study-level meta-analysis of efficacy data from head-to-head first-line trials of epidermal growth factor receptor inhibitors versus bevacizumab in patients with RAS wild-type metastatic colorectal cancer.
Eur J Cancer 2016;
67: 11-20
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.